Skip to content

Dutch Reading Test Study

Dutch Reading Test Study - DRT Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON38096
Enrollment
150
Registered
2012-12-10
Start date
2013-01-25
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glaucoma or other eye diseases macular degeneration

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Visual impairment according to Dutch Guidelines (Van Rens et al., 2011) - Acceptance of study conditions (informed consent) - Age of 18 years or older - Good understanding of the Dutch language - Stable eye condition at least three months and no progression expected the next month - Adequate cognitive ability to administer questionnaire

Exclusion criteria

Exclusion criteria: - Participant stays in a psychogeriatric of psychiatric institution - A disease or use of medication which delays reaction ability - Participant with dyslexia

Design outcomes

Primary

MeasureTime frame
Reading acuity and reading speed in words per minute and number of characters per minute. (1) Validation of different reading cards (2) Comparing usefulness of different reading cards (3) To examine the relationship between patient characteristics and reading performance on the different reading cards De patient characteristics that will be examined are - Distance visual acuity - Eye disease - Central visual field - Contrast sensitivity - Glare - Age - Gender - Education - Cognition - Health status

Secondary

MeasureTime frame
- Depression (Center for Epidemiological Studies * Depression scale: CES-D) - Co-morbidity (chronic disease questionnaire) - Vision related quality of life (Low Vision Quality Of Life questionnaire: LVQOL) - Rehabilitation needs (Dutch ICF Activity Inventory: D-AI)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)